Finch Therapeutics Group, Inc. (FNCHQ) vs NexImmune, Inc. (NEXI)
Finch Therapeutics Group, Inc. and NexImmune, Inc. are both Biotechnology companies. Finch Therapeutics Group, Inc. and NexImmune, Inc. are of similar size ($1.6M and $1.6M). Across the 7 metrics below, NexImmune, Inc. leads on 4 and Finch Therapeutics Group, Inc. on 3.
Valuation
Profitability
| Metric | FNCHQ | NEXI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (67.28%) | (232.97%) | (57.72%) |
| Return on assets | (25.20%) | (140.56%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack